Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Other | 80.5% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Unilever | 2.9% |
AstraZeneca | 2.8% |
BT Group | 2.7% |
Imperial Tobacco | 2.7% |
HSBC Holdings | 2.5% |
Centrica | 1.9% |
No asset data available.
Date | 23-Apr-2024 |
---|---|
NAV | 321.30p |
Currency | GBP |
Change | 2.70p |
% | 0.85% |
YTD change | 13.70p |
YTD % | 4.45% |
Fund Inception | 18/10/2004 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research